Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,397 | 80 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,068 | 11 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $908.08 | 28 | $0 (2022) |
| Novo Nordisk Inc | $368.09 | 5 | $0 (2022) |
| Amgen Inc. | $199.33 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $139.51 | 8 | $0 (2022) |
| ABBVIE INC. | $124.23 | 9 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $114.35 | 7 | $0 (2022) |
| Valeritas, Inc. | $105.93 | 1 | $0 (2017) |
| Eisai Inc. | $104.58 | 1 | $0 (2023) |
| Boston Scientific Corporation | $99.93 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $309.14 | 3 | AstraZeneca Pharmaceuticals LP ($113.30) |
| 2022 | $635.44 | 25 | Novo Nordisk Inc ($237.49) |
| 2021 | $543.06 | 14 | AstraZeneca Pharmaceuticals LP ($215.25) |
| 2020 | $362.90 | 8 | Janssen Pharmaceuticals, Inc ($128.22) |
| 2019 | $736.37 | 14 | AstraZeneca Pharmaceuticals LP ($328.77) |
| 2018 | $321.74 | 7 | Janssen Pharmaceuticals, Inc ($185.47) |
| 2017 | $488.76 | 9 | Janssen Pharmaceuticals, Inc ($192.51) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $104.58 | General |
| Category: Neurology | ||||||
| 04/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $91.26 | General |
| Category: Diabetes | ||||||
| 03/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $113.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Neuroscience | ||||||
| 11/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| Category: Cardiovascular | ||||||
| 09/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: WATCHMAN_IC | ||||||
| 07/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 05/19/2022 | Ethicon US, LLC | VISTASEAL (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Biosurgical | ||||||
| 05/17/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $83.46 | General |
| Category: WATCHMAN_IC | ||||||
| 05/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $100.49 | General |
| Category: Diabetes | ||||||
| 04/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 377 | 588 | $122,788 | $39,710 |
| 2022 | 8 | 391 | 590 | $114,745 | $37,323 |
| 2021 | 9 | 397 | 616 | $125,565 | $42,490 |
| 2020 | 11 | 507 | 712 | $137,597 | $47,755 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 123 | 276 | $52,655 | $16,324 | 31.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 85 | $22,011 | $7,696 | 35.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 97 | 107 | $20,690 | $6,388 | 30.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 60 | 62 | $15,018 | $5,440 | 36.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $8,680 | $2,718 | 31.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 30 | $3,734 | $1,145 | 30.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 138 | 297 | $49,005 | $16,024 | 32.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 77 | 80 | $19,520 | $6,488 | 33.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 67 | $15,812 | $5,223 | 33.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 68 | 71 | $11,786 | $3,442 | 29.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $8,370 | $2,804 | 33.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,508 | $1,802 | 32.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 20 | 20 | $3,320 | $1,059 | 31.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 16 | $1,424 | $481.17 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 128 | 264 | $43,560 | $14,842 | 34.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 110 | $25,960 | $8,831 | 34.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 63 | 65 | $15,860 | $5,299 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 27 | $12,393 | $4,108 | 33.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 27 | 28 | $8,680 | $2,978 | 34.3% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 17 | 18 | $5,544 | $1,891 | 34.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 28 | 28 | $4,648 | $1,577 | 33.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 28 | 28 | $4,648 | $1,520 | 32.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 48 | $4,272 | $1,443 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 161 | 327 | $53,955 | $18,772 | 34.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 83 | 90 | $21,960 | $7,610 | 34.7% |
About Dr. Paul Myers, DO
Dr. Paul Myers, DO is a Family Medicine healthcare provider based in Mount Pleasant, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1487811592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Myers, DO has received a total of $3,397 in payments from pharmaceutical and medical device companies, with $309.14 received in 2023. These payments were reported across 80 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,397).
As a Medicare-enrolled provider, Myers has provided services to 1,672 Medicare beneficiaries, totaling 2,506 services with total Medicare billing of $167,278. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Hospitalist
- Location Mount Pleasant, PA
- Active Since 05/19/2008
- Last Updated 01/31/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487811592
Products in Payments
- FARXIGA (Drug) $881.27
- XARELTO (Drug) $604.91
- INVOKANA (Drug) $287.41
- Rybelsus (Drug) $220.50
- BYDUREON (Drug) $173.33
- ENTRESTO (Drug) $139.51
- RYBELSUS (Drug) $130.60
- ELIQUIS (Drug) $114.35
- V-GO (Device) $105.93
- Leqembi (Drug) $104.58
- Repatha (Biological) $102.79
- WATCHMAN Access System (Device) $99.93
- Aimovig (Biological) $96.54
- MOUNJARO (Drug) $91.26
- UBRELVY (Drug) $86.15
- QULIPTA (Drug) $38.08
- VISTASEAL (Biological) $17.86
- SPRAVATO (Drug) $15.76
- OFEV (Drug) $15.47
- AVYCAZ (Drug) $15.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mount Pleasant
Robert Lambert, Md, MD
Family Medicine — Payments: $29,354
Donato Borrillo, M.d, M.D
Family Medicine — Payments: $13,183
Dr. Jeffrey Yonce, Md, MD
Family Medicine — Payments: $10,514
Alaina Payne, Md, MD
Family Medicine — Payments: $9,238
Vinitha Nareddy, M.d, M.D
Family Medicine — Payments: $9,026
Annu Mohan, M.d, M.D
Family Medicine — Payments: $8,226